School of Medicine


Showing 11-20 of 39 Results

  • Lisa Henriksen

    Lisa Henriksen

    Sr Research Engineer, Medicine - Stanford Prevention Research Center

    Current Research and Scholarly Interests My research aims to improve our understanding of the health risks associated with exposure to tobacco marketing and provide a scientific rationale for new policies to reduce it. I also study use of media to promote and discourage adolescent tobacco use, and the impact of tobacco advertising on urge and craving to smoke.

  • Tina Hernandez-Boussard

    Tina Hernandez-Boussard

    Associate Professor (Research) of Medicine (Biomedical Informatics), of Biomedical Data Science and of Surgery

    Current Research and Scholarly Interests My background and expertise is in the field of computational biology, with concentration in health services research. A key focus of my research is to apply novel methods and tools to large clinical datasets for hypothesis generation, comparative effectiveness research, and the evaluation of quality healthcare delivery. My research involves managing and manipulating big data, which range from administrative claims data to electronic health records, and applying novel biostatistical techniques to innovatively assess clinical and policy related research questions at the population level. This research enables us to create formal, statistically rigid, evaluations of healthcare data using unique combinations of large datasets.

  • Ann Hsing

    Ann Hsing

    Professor (Research) of Medicine (Stanford Prevention Research Center/Cancer Institute) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests Research Focus
    • Epidemiology of prostate, hepatobiliary, and thyroid cancers
    • Racial disparities in cancer
    • Endogenous hormones/growth factors
    • Circadian rhythms
    • Chronic inflammation
    • Genetic susceptibility
    • Cancer prevention and control
    • Global oncology and international studies

  • John P.A. Ioannidis

    John P.A. Ioannidis

    C. F. Rehnborg Professor in Disease Prevention in the School of Medicine, Professor of Medicine, of Health Research and Policy (Epidemiology) and by courtesy, of Statistics and of Biomedical Data Science

    Current Research and Scholarly Interests Meta-research
    Evidence-based medicine
    Clinical and molecular epidemiology
    Human genome epidemiology
    Research design
    Reporting of research
    Empirical evaluation of bias in research
    Randomized trials
    Statistical methods and modeling
    Meta-analysis and large-scale evidence
    Prognosis, predictive, personalized, precision medicine and health
    Sociology of science

  • Esther M. John

    Esther M. John

    Professor (Research) of Medicine (Oncology) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests Dr. John has extensive expertise in conducting population-based epidemiologic studies and has led as Principal Investigator multiple large-scale studies, including multi-center studies with a study site in the San Francisco Bay Area with its diverse population. Many of her studies and collaborations investigated cancer health disparities. Her research has focused on the role of modifiable lifestyle factors (e.g., body size, physical activity, diet), hormonal factors, early-life exposures, genetic variants, and gene-environment interactions; differences in risk factors by race/ethnicity, breast cancer subtypes, and prostate cancer subtypes; risk factors for familial breast cancer and second primary breast cancer, as well as prognostic factors related to survival disparities.

    As Principal Investigator, Dr. John has led a number of studies conducted in the San Francisco Bay Area, including:

    - the Northern California site of the Breast Cancer Family Registry, an on-going prospective multi-generational cohort of over 13,000 families established in 1995 at six international sites;
    - the Northern California site of the WECARE Study that investigates risk factors for second primary breast cancer;
    - the California site of the Breast Cancer Health Disparities Study that investigated genetic variability and breast cancer risk and survival in Hispanic and non-Hispanic white populations in the context of genetic admixture;
    - the Breast Cancer Etiology in Minorities (BEM) Study, a pooled analysis of risk factors for breast cancer subtypes in racial/ethnic minorities;
    - the San Francisco Bay Area Breast Cancer Study, a population-based case-control study in nearly 5,000 Hispanic, African American and non-Hispanic white women that investigated the role of modifiable lifestyle factors and other risk factors;
    - the San Francisco Bay Area Prostate Cancer Study, a population-based case-control study of lifestyle and genetic risk factors for advanced and localized disease.

    These studies collected and pooled extensive data and biospecimens and continue to support numerous ancillary studies, collaborations and international consortia and have contributed to a better understanding of cancer risk and survival in racial/ethnic minority populations.

    Dr. John is also a founding PI of the LEGACY Girls Study, an on-going prospective cohort established in 2011 that investigates early life exposures in relation to pubertal development outcomes, breast tissue characteristics, and behavioral and psychosocial outcomes in the context of having a family history or breast cancer.

  • Abby C. King

    Abby C. King

    Professor of Health Research and Policy (Epidemiology) and of Medicine (Stanford Prevention Research Center)

    Current Research and Scholarly Interests My interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.

  • Allison W. Kurian, M.D., M.Sc.

    Allison W. Kurian, M.D., M.Sc.

    Associate Professor of Medicine (Oncology) and of Health Research and Policy at the Stanford University Medical Center

    Current Research and Scholarly Interests I aim to improve the outcomes of women's cancers through clinically-oriented research on genetic risk assessment, risk-adapted screening and prevention.

  • Uri Ladabaum

    Uri Ladabaum

    Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University School of Medicine

    Current Research and Scholarly Interests Gastrointestinal cancer prevention and risk management. Risk stratification. Cost-effectiveness analysis. Health services research.

  • Jennifer Lee

    Jennifer Lee

    Associate Professor of Medicine (Endocrinology) and, by courtesy, of Health Research and Policy (Epidemiology) at the Palo Alto Veterans Affairs Health Care System

    Current Research and Scholarly Interests I am a clinical scientist (PhD epidemiology), endocrinologist, and CMO at VAPA Cooperative Studies Program Coordinating Center . My group does pattern and prediction mapping along the life-course of interventions/outcomes and how healthcare system can positively impact health longitudinally. We use novel molecular epi, 'big' data like EHRs with advanced new designs/methods/technologies. These interests cut across multiple complex chronic diseases, aging, & critical lifespan stages.

  • Eleni Linos, MD, MPH, DrPH

    Eleni Linos, MD, MPH, DrPH

    Professor of Dermatology at the Stanford University Medical Center and, by courtesy, of Health Research and Policy (Epidemiology)

    Bio Eleni Linos MD, MPH, DrPH, is Professor of Dermatology at Stanford University. Her work focuses on public health, cancer prevention and geriatric dermatology. Dr. Linos is dually trained in epidemiology and dermatology and is the principal investigator of several NIH funded studies aimed at improving the lives of patients with skin disease. She received her medical degree from Cambridge and Oxford universities in the UK, then trained in epidemiology at the Harvard School of Public Health and completed her dermatology residency at Stanford.